Amanote Research
Register
Sign In
Evidence for Differential Acquired Drug Resistance to Anti-Tumour Necrosis Factor Agents in Rheumatoid Arthritis
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.2005.045062
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
June 1, 2006
Authors
A Finckh
Publisher
BMJ
Related search
Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumour Necrosis Factor Α Inhibitors: Cohort Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Editorial: Tacrolimus vs. Anti-Tumour Necrosis Factor Agents for Moderately to Severely Active Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Comparison of the Efficacy of the Tumour Necrosis Factor Blocking Agents Adalimumab, Etanercept, and Infliximab When Added to Methotrexate in Patients With Active Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Tumour Necrosis Factor Gene Polymorphisms in Egyptian Patients With Rheumatoid Arthritis and Their Relation to Disease Activity and Severity
Central-European Journal of Immunology
Allergy
Immunology
Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Anti-Tumour Necrosis Factor Therapy for Ankylosing Spondylitis: International Experience
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Role of Anti-Inflammatory and Immunomodulatory Agents in Rheumatoid Arthritis.
Al-Azhar Journal of Pharmaceutical Sciences
Cost-Effectiveness of Combination Disease-Modifying Antirheumatics vs. Tumour Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: TACIT Trial
Arthritis Care and Research
Rheumatology
Anti-Tumour Necrosis Factor Antibody Treatment Does Not Change Serum Levels of Cortisol Binding Globulin in Patients With Rheumatoid Arthritis but It Increases Androstenedione Relative to Cortisol
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics